Evidence map›Paper›PMID 36645671›Full record

ArticlePhysiological genomics2023

Na

Toya Motoshima, Ayumi Nagashima, Chihiro Ota, Haruka Oka, Kohei Hosono, Ingo Braasch, Hidenori Nishihara, Akira Kato

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Physiological genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Animals : an open access journal from MDPI · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Toya MotoshimaSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.
Ayumi NagashimaSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.ORCID 0000-0002-0736-0928
Chihiro OtaSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.
Haruka OkaSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.
Kohei HosonoSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.
Ingo BraaschDepartment of Integrative Biology, College of Natural Science, Michigan State University, East Lansing, Michigan, United States.ORCID 0000-0003-4766-611X
Hidenori NishiharaSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.ORCID 0000-0002-5843-9994
Akira KatoSchool of Life Science and Technology, Tokyo Institute of Technology, Yokohama, Japan.ORCID 0000-0002-9083-1443
Tokyo Institute of Technology · JPMichigan United · US

Funding

Resources for Teleost Gene Duplicates and Human DiseaseR01OD011116 · OD · UNIVERSITY OF OREGON · PI POSTLETHWAIT, JOHN H. · 2012 to 2020
$5.4M
NIH HHS R01 OD011116
6 · The paper itself

Abstract

Solute carrier 12 (Slc12) is a family of electroneutral cation-coupled chloride (Cl

Indexed as

PlatypusAmphibiansAnimalsBirdsCattleFemaleFishesHorsesHumansMicePhylogenyReptilesSolute Carrier Family 12, Member 3SLC12A3 protein, humanSolute Carrier Family 12, Member 3evolutionNcc2pseudogenizationSlc12a10Slc12a3

Identifiers

PMID36645671
PMCPMC9988527
OpenAlexW4316500535

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.